secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kairos Pharma, LTD. (KAPA)
CIK:        0001962011
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001493152-24-040780
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kairos Pharma CEO to speak at Maxim Healthcare Virtual Summit; investor deck updated
--------------------------------------------------------------------------------

- CEO Dr. John S. Yu will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit (Oct 15-17).
- Company posted an updated corporate presentation on its website at www.kairospharma.com.
- No financial results or material operational updates were disclosed in the filing or attached deck.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1962011/000149315224040780/0001493152-24-040780-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1962011/000149315224040780/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-040780

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer